THE 2023 ANNUAL MEETING
ABSTRACTS OF INTEREST
ECOG-ACRIN E2197: Comparison of HER2 gene expression by RT-PCR across all HER2 immunohistochemistry groups with recurrence analysis
Authors
Thuy Can, John P. Bennett, Cynthia A. Flannery, Helen Bailey, Joseph Sparano, Frederick L. Baehner, and Sunil Badve
Abstract Number
515
SEER Analysis of 9-year breast cancer specific mortality (BCSM) in patients (pts) with invasive lobular breast cancer (ILC) assessed by the 21-gene Breast Recurrence Score assay.
Authors
Charles E. Geyer Jr. MD, John Bennett MPH, Gong Tang PhD, Jennifer M. Racz MD, Christy Ann Russell MD, Jung Byun, Julia Foldi MD Ph, Frederick L. Baehner MD, Valentina I. Petkov MD MPH
Abstract Number
554
Outcomes in participants with false positive multi-cancer early detection (MCED) test: Results from >4 years follow-up from DETECT-A, the first large, prospective, interventional MCED study
Authors
Anne Marie Lennon, Adam H. Buchanan, Seema P. Rego, Omair A. Choudhry, Paul Z. Elias, Jennifer R. Sadler, Joshua D. Cohen, Christopher B. Douville, Ashley Honushefsky, Alison Klein, Zachary M. Salvati, Kathleen Sheridan, Cristian Tomasetti, Eric S. Wagner, Carroll N. Walter, Elliot K. Fishman, Kenneth W. Kinzler, Bert Vogelstein, Tomasz M. Beer, Nickolas Papadopoulos
Abstract Number
3039
Genomic profiling of biliary tract carcinomas by their location
Authors
Zoran Gatalica, David Edwards, Cynthia Flannery, David W. Hall, Jess Hoag, Nishitha Therala, Janine LoBello, Snehal Thakkar, Gargi Basu, Maen Abdelrahim
Abstract Number
e16175
Correlation of Unobserved Incidence of Cancer in Earlier Stages is Substantially Higher Than the Observed Incidence
Authors
Jagpreet Chhatwal, Andrew K. ElHabr, Christopher Tyson, Xiting Cao, Selin Merdan, Sana Raoof, A. Burak Ozbay, A. Mark Fendrick, Paul Limburg, Tomasz M. Beer, Ashish Deshmukh
Abstract Number
10634
Long-term clinical outcomes of cancers diagnosed following detection by a blood-based multi-cancer early detection (MCED) test
Authors
Adam Buchanan, Anne Marie Lennon, Seema Rego, Omair Choudhry, Paul Elias, Jennifer Sadler, Joshua Cohen, Christopher Douville, Ashley Honushefsky, Alison Klein, Zachary Salvati, Kathleen Sheridan, Cristian Tomasetti, Eric Wagner, Carroll Walter, Elliot Fishman, Kenneth Kinzler, Bert Vogelstein, Tomasz Beer, Nickolas Papadopoulos
Abstract Number
3037
A flexible quantitative framework to assess the potential contribution of early cancer detection to improved cancer survival
The detection of multiple cancer types with an extended set of methylation protein markers
Authors
Slava E. Katerov, Harrison Fleming, Debra Rugowski, Justin Heilberger, Tyler Duellman, Jillian Kirby, Nick Kirchner, Brittany Melah, Jacquelyn Hennek, Hatim T. Allawi
Abstract Number
3040
Validating the Use of Machine-Learning Cancer Staging Algorithms for Medicare Cost Analysis
Authors
Rebecca Smith, Lesley-Ann Miller-Wilson, Gebra Cuyun Carter, Ifrah Fayyaz; Andreyah Pope, Bruce Pyenson
Abstract Number
e13548
The impact of extending CRC screening to the older population – results from CRC-AIM microsimulation model
Authors
Derek W. Ebner, John B. Kisiel, Chris Estes, Vahab Vahdat, Paul Limburg
Abstract Number
10567
Estimated life-years gained and resultant cost savings from follow-up colonoscopy after a positive multi-target stool DNA (mt-sDNA) test for colorectal cancer screening in commercially insured and Medicare populations
Authors
A. Mark Fendrick, John B. Kisiel, Derek W. Ebner, Vahab Vahdat, A. Burak Ozbay, Chris Estes, Paul Limburg
Abstract Number
6642
Estimated value-based pricing for blood-based colorectal cancer screening test versus multi-target stool DNA test
Authors
John B. Kisiel, A. Mark Fendrick, Bijan J. Borah, Derek W. Ebner, A. Burak Ozbay, Vahab Vahdat, Chris Estes, Paul Limburg
Abstract number
e18911
Colorectal cancer screening with blood-based tests: Estimated impact of a 1-, 2-, or 3-year screening interval compared with annual FIT and triennial mt-sDNA strategies
Authors
A. Mark Fendrick, David Lieberman, John B. Kisiel, A. Burak Ozbay, Vahab Vahdat, Chris Estes, Paul Limburg
Abstract Number
10580
Patient-Provider Communication Factors Associated with mt-sDNA Screening for Colorectal Cancer
Authors
Lila J. Finney Rutten, Xuan Zhu, Linda Squiers, Leah Helmueller, Brian Southwell, Carlye Gates, Shama Alam, Bonny Kneedler, Paul Limburg
Abstract number
e22514
Treatments and clinical outcomes in stage II colon cancer (CC) patients (pts) with 12-gene Oncotype DX Colon Recurrence Score assay-guided therapy: Real-world data.
Authors
Baruch Brenner, MD, Katerina Shulman, MD, Ayala Hubert, MD, Sophia Man, MD, Ravit Geva, MD, Irit Ben-Aharon, MD, Shlomit Fennig, MD, Moshe Mishaeli, MD, Nirit Yarom, MD, Gil Bar-Sela, MD, Ronen Brenner, MD, Ayelet Shay, MD, PhD, Lior Soussan-Gutman, PhD, Hillary Voet, PhD, Avital Bareket-Samish, PhD, Nicky Liebermann, MD
Abstract Number
3620